Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China

Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China

Background. The aim of this study was to compare the daily costs and cost effectiveness of fixed combination glaucoma drugs in China. Methods. This study included the following fixed combination drugs: brinzolamide 1% and timolol 0.5% (Azarga; Alcon, Inc., Fort Worth, TX, USA), travoprost 0.004% and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chenjia Xu, Ruru Guo, Dandan Huang, Jian Ji, Wei Liu
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2020/2406783
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Influence of Cost of Care and Adherence in Glaucoma Management: An Update
by: Frances Meier-Gibbons, et al.
Published: (2020-01-01)

A Novel, Low-Cost Glaucoma Calculator to Identify Glaucoma Patients and Stratify Management
by: Daniel Laroche, et al.
Published: (2022-01-01)

Internal audit of costs on fixed assets repair
by: M.Yu. Samchyk
Published: (2016-12-01)

Low-cost do-it-yourself (DIY) kit for glaucoma procedures
by: Indira Pegu, et al.
Published: (2025-03-01)

Antioxidant activity of dorzolamide/timolol fixed combination in neuroprotective therapy in glaucoma
by: N. I. Kurysheva, et al.
Published: (2014-07-01)

Latanoprost/timolol fixed combination in the treatment of primary open-angle glaucoma
by: S. Yu. Petrov, et al.
Published: (2025-03-01)

Outcome of a Low-Cost Glaucoma Implant versus the Baerveldt Glaucoma Implant for Paediatric Glaucoma in a Tertiary Hospital in Egypt
by: Mahmoud F. Rateb, et al.
Published: (2019-01-01)

Cost-effectiveness of camrelizumab combined with chemotherapy in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma in China
by: Rui Guo, et al.
Published: (2023-12-01)

Effectiveness and safety of hypotensive therapy of primary glaucoma with a Russian generic fixed combination of dorzolamide and timolol
by: S. Yu. Petrov, et al.
Published: (2022-09-01)

Analysis of acquisition and the monthly cost of antihypertensive therapy with modern fixed-dose combinations in the Far Eastern Federal District
by: M. S. Soboleva, et al.
Published: (2021-04-01)

Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain
by: Santiago Moreno Guillen, et al.
Published: (2017-09-01)

Features of the Effect of Cataracts and Glaucoma on the Daily Activities of Patients with Sarcopenic Obesity
by: O. L. Fabrikantov, et al.
Published: (2024-12-01)

Efficiency and safety of the fixed latanoprost/ dorzolamide combination in open-angle glaucoma hypotensive treatment
by: V. V. Neroev, et al.
Published: (2023-10-01)

Taking stock of cost-effectiveness analysis of healthcare in China
by: Thomas Butt, et al.
Published: (2019-06-01)

Cost-effectiveness of combining AI and cfDNA with LDCT for lung cancer screening in China: a modelling study
by: Mingjun Rui, et al.
Published: (2025-02-01)

Association Between Fixed-Dose Combination Use and Medication Adherence, Health Care Utilization, and Costs Among Medicaid Beneficiaries
by: Donglan Zhang, PhD, et al.
Published: (2025-09-01)

A comparative evaluation of efficiency of fixed combination hypotensives for the treatment of primary open-angle glaucoma
by: F. A. Bakhritdinova, et al.
Published: (2018-10-01)

Development of a Cost-Efficient and Glaucoma-Specialized OD/OC Segmentation Model for Varying Clinical Scenarios
by: Kai Liu, et al.
Published: (2024-11-01)

Price tag of glaucoma care is minor compared with the total direct and indirect costs of glaucoma: Results from nationwide survey and register data.
by: Petri K M Purola, et al.
Published: (2023-01-01)

Cost-effectiveness analysis of nimotuzumab combined with gemcitabine for K-Ras wild type locally advanced or metastatic pancreatic cancer in China
by: Rong Long, et al.
Published: (2025-02-01)

PRESERVATIVE-FREE FIXED COMBINATION OF BIMATOPROST AND TIMOLOL IN THE EVOLUTION OF COMPLIANCE AND TREATMENT EFFECTIVENESS IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA
by: I. A. Loskoutov, et al.
Published: (2018-10-01)

Cost of an urban rail ride: A nation-level analysis of ridership, capital costs and cost-effectiveness performance of urban rail transit projects in China
by: Jinbao Zhao, et al.
Published: (2018-11-01)

An equation for tacrolimus daily dose calculation in renal transplant patients - simple and cost saving?
by: Rančić Nemanja, et al.
Published: (2018-01-01)

COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA
by: N. L. Pogudina, et al.
Published: (2017-08-01)

Cost-Effectiveness of Combination Therapy for Chronic Obstructive Pulmonary Disease
by: Anderson Chuck, et al.
Published: (2008-01-01)

Efficiency and safety of the latanoprost and dorzolamide fixed combination in primary open-angle glaucoma initial hypotensive treatment
by: V. V. Neroev, et al.
Published: (2025-03-01)

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS
by: M. V. Protsenko
Published: (2015-03-01)

Comparison of Presbyopia Between Glaucoma Patients Using Prostaglandin F Receptor Agonists and Fixed Combination Therapy
by: Ayaki M, et al.
Published: (2025-06-01)

Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China
by: Rongqi Li, et al.
Published: (2024-12-01)

Evaluation of the Effectiveness of Using a Fixed Combination of Dorzolamide 2.0 % and Timolol 0.5 % in Primary Open-Angle Glaucoma
by: S. S. Khaldeev, et al.
Published: (2024-06-01)

Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study
by: Maureen Rutten-van Mölken, et al.
Published: (2021-08-01)

Estimated health benefits, costs and cost-effectiveness of eliminating dietary industrial trans fatty acids in Kenya: cost-effectiveness analysis
by: J Lennert Veerman, et al.
Published: (2023-10-01)

Service delivery costs of vaccination at health facilities in Guangzhou, China
by: Chunhuan Zhang, et al.
Published: (2025-12-01)

Can the Fixed-Cost Transportation Problem Be Solved with the Initial Solution Methods of the Transportation Problem?
by: Kenan Karagül
Published: (2024-09-01)

Preservative free travoprost and timolol fixed combination in the initial treatment of primary glaucoma: an assessment of hypotensive efficiency and safety
by: S. Yu. Petrov, et al.
Published: (2022-01-01)

An assessment of China’s methane mitigation potential and costs and uncertainties through 2060
by: Nina Khanna, et al.
Published: (2024-11-01)

Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections
by: Miguel Figallo, et al.
Published: (2024-01-01)

Cost-effectiveness of a national enterovirus 71 vaccination program in China.
by: Wenjun Wang, et al.
Published: (2017-09-01)

Cost-utility analysis of omalizumab for the treatment of chronic spontaneous urticaria in China
by: Yueyang Huang, et al.
Published: (2025-07-01)

Digital Image Analysis of the Angle and Optic Nerve: A Simple, Fast, and Low-Cost Method for Glaucoma Assessment
by: Greg Russell, et al.
Published: (2020-01-01)